News Snapshot:
China is on track to approve its first drug for Covid-19 , possibly within weeks. This comes as Chinese scientists race to find an effective treatment for the disease, crucial for the country with a zero-tolerance strategy before it can consider reopening its borders, even as vaccination remains a priority. Conditional approval may be given to a neutralising monoclonal antibody treatment co-developed by Chinese and US researchers by the end of the year, according to an official publication of the Ministry of Science and Technology. Brii Biosciences, a multinational pharmaceutical firm based in the US and China, developed the therapy...
